Rapid Point-Of-Care Breath Test for Biomarkers of Breast Cancer and Abnormal Mammograms

Autor: Roy I. Lalisang, Peter D. Kaplan, Marc B. I. Lobbes, Mayur Mundada, J. David Beatty, Urvish Patel, Nadine Pappas, Jan Huston, Michael Phillips, Renee N. Cataneo, Philippe Lambin
Přispěvatelé: Interne Geneeskunde, Radiotherapie, MUMC+: DA BV Medisch Specialisten Radiologie (9), RS: GROW - Oncology, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy
Jazyk: angličtina
Rok vydání: 2014
Předmět:
Oncology
Pathology
Epidemiology
Papillary Carcinomas
Invasive Ductal Carcinoma
lcsh:Medicine
Diagnostic Radiology
Benign Breast Tumors
0302 clinical medicine
Area under curve
Cancer screening
Breast Tumors
Young adult
skin and connective tissue diseases
lcsh:Science
0303 health sciences
Chromatography
Multidisciplinary
medicine.diagnostic_test
Carcinoma
Ductal
Breast

3. Good health
Chemistry
Ductal Carcinoma in Situ
Breath Tests
030220 oncology & carcinogenesis
Area Under Curve
Medicine
Female
Invasive Lobular Carcinoma
Radiology
Monte Carlo Method
Cancer Screening
Mammography
Research Article
Biotechnology
Adult
medicine.medical_specialty
Drugs and Devices
Adolescent
Point-of-Care Systems
Breast Neoplasms
Bioengineering
Medical Devices
03 medical and health sciences
Young Adult
Breast cancer
Diagnostic Medicine
Internal medicine
Biopsy
medicine
Biomarkers
Tumor

Cancer Detection and Diagnosis
Early Detection
Humans
Biology
030304 developmental biology
Point of care
Gas Chromatography
Breath test
business.industry
lcsh:R
Cancers and Neoplasms
medicine.disease
Biomarker Epidemiology
ROC Curve
Multivariate Analysis
Women's Health
lcsh:Q
business
Biomarkers
General Pathology
Zdroj: PLOS ONE, 9(3):e90226. Public Library of Science
PLoS ONE, Vol 9, Iss 3, p e90226 (2014)
PLoS ONE
ISSN: 1932-6203
Popis: Background: Previous studies have reported volatile organic compounds (VOCs) in breath as biomarkers of breast cancer and abnormal mammograms, apparently resulting from increased oxidative stress and cytochrome p450 induction. We evaluated a six-minute point-of-care breath test for VOC biomarkers in women screened for breast cancer at centers in the USA and the Netherlands. Methods: 244 women had a screening mammogram (93/37 normal/abnormal) or a breast biopsy (cancer/no cancer 35/79). A mobile point-of-care system collected and concentrated breath and air VOCs for analysis with gas chromatography and surface acoustic wave detection. Chromatograms were segmented into a time series of alveolar gradients (breath minus room air). Segmental alveolar gradients were ranked as candidate biomarkers by C-statistic value (area under curve [AUC] of receiver operating characteristic [ROC] curve). Multivariate predictive algorithms were constructed employing significant biomarkers identified with multiple Monte Carlo simulations and cross validated with a leave-one-out (LOO) procedure. Results: Performance of breath biomarker algorithms was determined in three groups: breast cancer on biopsy versus normal screening mammograms (81.8% sensitivity, 70.0% specificity, accuracy 79% (73% on LOO) [C-statistic value], negative predictive value 99.9%); normal versus abnormal screening mammograms (86.5% sensitivity, 66.7% specificity, accuracy 83%, 62% on LOO); and cancer versus no cancer on breast biopsy (75.8% sensitivity, 74.0% specificity, accuracy 78%, 67% on LOO). Conclusions: A pilot study of a six-minute point-of-care breath test for volatile biomarkers accurately identified women with breast cancer and with abnormal mammograms. Breath testing could potentially reduce the number of needless mammograms without loss of diagnostic sensitivity.
Databáze: OpenAIRE